This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
Chinese to English - Rates: 0.06 - 0.11 USD per character / 40 - 40 USD per hour English to Chinese - Rates: 0.06 - 0.11 USD per word / 40 - 40 USD per hour
English to Chinese: Free Wheelchair Mission - Transforming lives through the gift of mobility General field: Other Detailed field: Medical: Health Care
Source text - English Free Wheelchair Mission - Transforming lives through the gift of mobility
Mission & Values
Our Mission is to provide the transforming gift of mobility to people with disabilities in developing nations as motivated by Jesus Christ.
Our Vision is to be a world-class provider of mobility, transforming the lives of 100,000 people with disabilities annually.
Free Wheelchair Mission’s Values are:
We honor God in all we do.
We pursue excellence in all our work.
We strive for efficiency to optimize resources.
We commit to transparency in our relationships, operations and finances.
We encourage worldwide collaboration.
We innovate to provide transformative mobility solutions
History
Free Wheelchair Mission was established in as a faith-based, non-profit organization with 501(c)(3) status in 2001. Through the vision of the President and Founder, Don Schoendorfer, Free Wheelchair Mission created a sturdy yet inexpensive wheelchair specifically designed for the estimated 100 million disabled poor in developing countries. In most developing countries, the disabled poor must crawl on the ground or wait to be carried by loved ones. They are victims of polio, birth defects, viral infections, accidents, brutal mutilations, land mines, and warfare.
Free Wheelchair Mission provides a basic wheelchair using strong mountain bike wheels, a tough, resin chair, and a single-piece steel frame, called GEN_1. In 2009 we introduced a second design that comes in three different sizes with adjustable features like seat depth, backrest and footrest height called GEN_2. We manufacture the wheelchairs in China and ship them by ocean container directly to developing countries. The wheelchairs are given to the poorest of the poor at no cost.
FWM Operations
Free Wheelchair Mission is truly a worldwide organization. While funding is sought primarily from US supporters, we have been expanding our reach and motivating supporters from all corners of the world. FWM is mainly supported by individuals who have a heart for individuals living with disabilities. We have also had success in building relationships with corporations, grant foundations and civic groups, to gain support. Free Wheelchair Mission utilizes an organizational model that leverages development and support efforts alongside an extremely economical design. A vast network of manufacturing, shipping and distribution partners have all partnered with FWM to help give people wheelchairs. The resulting system stretches donor dollars and maximizes beneficial impact on a global scale.
English to Chinese: Service agreement General field: Law/Patents Detailed field: Law: Contract(s)
Source text - English Disclaimer of Warranties
The Services are intended for educational, research, self-study, and reference purposes only. The Services are not intended to substitute for the exercise of professional judgment by the user. Medical science and clinical practice is ever-changing. Users, whenever possible, are advised to confirm the information available from the Services through independent sources. The information available through the Services should not be substituted for the advice or judgement of a qualified health care professional. Do not disregard or avoid professional medical advice or delay seeking it because of materials made available through the Services. The Massachusetts Medical Society (“MMS”) makes no warranty that the operation of the Services will be uninterrupted or error-free or as to the accuracy, completeness, suitability, or result obtained from the use of the Services or any content included therein.
[...]
Limitations of Liability
To the maximum extent permitted by applicable law and notwithstanding any other provision of these terms of use, in no event shall MMS (including any of its partners, affiliates, officers, directors, agents, subsidiaries, joint ventures, members, employees, contractors, successors, or assignees and third-party service providers) be liable to you (including any of your partners, officers, employees, agents, contractors, successors, heirs or assignees) for any indirect, special, incidental, exemplary, punitive, or consequential damages, whether arising in contract, equity, negligence, intended conduct, tort, or otherwise (including breach of warranty, negligence, and strict liability in tort), including, without limitation, any errors or omissions in the content of the services, for your action or inaction in connection with the services, for any damage to your computer or data, any damages associated with the loss of your personal information or any other damage or economic loss you may incur ensuing from or in connection with (a) the services; or (b) your submission of personal or other information through the services, even if MMS or any of its affiliates have been advised of the possibility of such damages. These limitations shall apply notwithstanding the failure of the essential purpose of any limited remedy.
Translation - Chinese 质量保证免责声明
该服务仅限于教育、研究、自学和参考用途。该服务无意代替用户进行专业判断。医学和临床实践不断变化。无论何时，只要有可能，我们都建议用户通过独立渠道确认本服务提供的信息。本服务提供的信息不应用来取代合格的医疗专业人士的建议或判断。不要因为本服务提供的资料，而漠视或回避专业的医疗建议，或延迟寻求这种建议。马萨诸塞州医学协会（“MMS”）不保证该服务的运作不间断或准确无误，也不保证因使用该服务或其中包含的任何内容而得到的准确性、完整性、适用性或结果。
English to Chinese: Immunology General field: Medical Detailed field: Medical (general)
Source text - English IL-10 is an anti-inflammatory cytokine. During infection it inhibits the activity of Th1 cells, NK cells, and macrophages, all of which are required for optimal pathogen clearance but also contribute to tissue damage. In consequence, IL-10 can both impede pathogen clearance and ameliorate immunopathology. Many different types of cells can produce IL-10, with the major source of IL-10 varying in different tissues or during acute or chronic stages of the same infection. The priming of these various IL-10-producing populations during infections is not well understood and it is not clear whether the cellular source of IL-10 during infection dictates its cellular target and thus its outcome. In this article we review the biology of IL-10, its cellular sources, and its role in viral, bacterial, and protozoal infections.
Translation - Chinese IL-10是一种消炎的细胞活素。感染期间，IL-10抑制Th1细胞、NK细胞和巨噬细胞的活动，要最好地清除病原体，需要具备所有这些细胞，但同时，它们可以造成组织的损害。因此，IL-10既可以阻碍病原体的清除，也可以改善免疫病理表现。很多不同类型的细胞都可以制造IL-10，在不同的组织中，或在同样感染的急性期或慢性期，IL-10的主要来源有所不同。这些制造IL-10的不同细胞群体在感染期间的激活仍未得到完全了解，同时，尚不清楚在感染期间，IL-10的细胞来源是否决定其细胞标靶，以及因而得到的结果。在本文中，我们回顾了IL-10的生物性、细胞来源以及其在病毒、细菌和原虫性感染中的作用。
English to Chinese: Plato's Epistemology and Metaphysics: The Myth of the Cave General field: Social Sciences Detailed field: Philosophy
Source text - English In the Meno, another early dialogue, Plato gives a detailed argument (again through the character of Socrates) for his view that not only is knowledge possible, but you already had it but lost it at birth: knowledge is in fact recollection. He uses a slave to show that even someone completely uneducated has the capacity for understanding and that this capability demonstrates that the soul once knew what it has now forgotten. Otherwise, such a feat would, according to him, be impossible. This theory – that knowledge ultimately comes from within, that it is already in you, waiting to be discovered – will become one of the most recurrent themes in subsequent philosophy.
Translation - Chinese 在另一个早期对话《美诺》（Meno）中，柏拉图提出一个详细的论述（再一次，通过苏格拉底这个人物），阐述他的观点，即认识不单是可能的，而且，你早已拥有认识，但在出生时丧失了这种本质：认识实际上是重新得到。他用奴隶来说明，即使完全未受教育的一个人，也具备理解的能力，同时，这种能力表明，灵魂曾经知道现在忘却的东西。否则，根据他的看法，这样的成就是不可能实现的。这种理论——即认识最终源自内在，它早已在你的内部，等待被发现——将成为随后的哲学中最反复出现的主题之一。
English to Chinese: Corporate quarterly statement General field: Bus/Financial
Source text - English Income from operations (EBIT) before special items declined by €110 million year on year to €1,640 million. This was mainly attributable to significantly lower contributions from the Chemicals and Materials segments and from Other. By contrast, we increased EBIT before special items in all other segments. The Surface Technologies and Nutrition & Care segments saw a considerable improvement in EBIT before special items, and the Agricultural Solutions and Industrial Solutions segments posted slight growth.
Special items in EBIT totaled minus €184 million in the first quarter of 2020, compared with €29 million in the prior-year quarter. These mainly related to integration costs for the businesses acquired from Solvay and to various restructuring measures. In the prior-year quarter, income from divestitures led to positive special items overall.
Translation - Chinese 除去特别项目之外的运营收入（息税前收益）与去年同期相比下跌1.10亿欧元，至16.40亿欧元。主要原因是化工和材料的业务领域以及其他业务领域的贡献大幅缩减。与此相反，在所有其他业务领域上，我们均提高了不含特别项目的息税前收益。在不计算特别项目在内的息税前收益上，表面处理技术以及营养与护理的业务领域出现显著提升，而农业解决方案以及工业解决方案的业务领域则获得小幅增长。
Member since Mar '13
Expertise